Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2020
Can CSF biomarkers predict future MS disease activity and severity?
Roberta Magliozzi, Anne H Cross
Expert Opinion on Therapeutic Targets
|
September 9, 2020
The BAFF / APRIL system as therapeutic target in multiple sclerosis
Roberta Magliozzi, Damiano Marastoni, Massimiliano Calabrese
Frontiers in Neurology
|
September 30, 2021
Editorial: B Cells in Inflammatory and Neurodegenerative Diseases of the Central Nervous System
Francesca Gilli, Roberta Magliozzi, Laura Piccio
Frontiers in Immunology
|
November 18, 2024
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II
Maria Teresa Cencioni, Luisa Maria Villar, Roberta Magliozzi
International Journal of Molecular Sciences
|
November 6, 2020
Intrathecal Inflammation in Progressive Multiple Sclerosis
Salvatore Monaco, Richard Nicholas, Richard Reynolds, et al.
Journal of Neuroimmunology
|
February 21, 2004
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
Roberta Magliozzi, Sandra Columba-Cabezas, Barbara Serafini, et al.
Nature Reviews. Neurology
|
July 3, 2023
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis
Roberta Magliozzi, Owain W Howell, Massimiliano Calabrese, et al.
Expert Opinion on Pharmacotherapy
|
February 6, 2018
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables
Marco Pitteri, Roberta Magliozzi, Albulena Bajrami, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 17, 2016
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
Marco Pitteri, Chiara Romualdi, Roberta Magliozzi, et al.
Brain Pathology (Zurich, Switzerland)
|
June 15, 2004
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
Barbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2020
Can CSF biomarkers predict future MS disease activity and severity?
Roberta Magliozzi, Anne H Cross
Expert Opinion on Therapeutic Targets
|
September 9, 2020
The BAFF / APRIL system as therapeutic target in multiple sclerosis
Roberta Magliozzi, Damiano Marastoni, Massimiliano Calabrese
Frontiers in Neurology
|
September 30, 2021
Editorial: B Cells in Inflammatory and Neurodegenerative Diseases of the Central Nervous System
Francesca Gilli, Roberta Magliozzi, Laura Piccio
Frontiers in Immunology
|
November 18, 2024
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II
Maria Teresa Cencioni, Luisa Maria Villar, Roberta Magliozzi
International Journal of Molecular Sciences
|
November 6, 2020
Intrathecal Inflammation in Progressive Multiple Sclerosis
Salvatore Monaco, Richard Nicholas, Richard Reynolds, et al.
Journal of Neuroimmunology
|
February 21, 2004
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
Roberta Magliozzi, Sandra Columba-Cabezas, Barbara Serafini, et al.
Nature Reviews. Neurology
|
July 3, 2023
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis
Roberta Magliozzi, Owain W Howell, Massimiliano Calabrese, et al.
Expert Opinion on Pharmacotherapy
|
February 6, 2018
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables
Marco Pitteri, Roberta Magliozzi, Albulena Bajrami, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 17, 2016
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
Marco Pitteri, Chiara Romualdi, Roberta Magliozzi, et al.
Brain Pathology (Zurich, Switzerland)
|
June 15, 2004
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
Barbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, et al.
Page
of 9